In contrast, aberrant or excessive activation of the cGAS–STING pathway can cause primary pathogenesis and the manifestation of several autoimmune diseases; thus, identifying compounds, delivery pathways, and treatment regimens targeting the suppression of the cGAS–STING pathway can provide novel approaches to alleviate the symptoms of autoimmune disorders or inflammation. Here, STING1 is linked to autoimmune disease.